Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001141 |
---|---|
Receipt number | R000001385 |
Scientific Title | Phase I Study of gemtuzumab ozogamicin in combination with cytarabinne and daunorubicin as induction therapy for relapsed or refractory patients with acute myeloid leukemia. |
Date of disclosure of the study information | 2008/05/10 |
Last modified on | 2011/10/31 16:00:38 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2008/04/30 18:31:20 | ||
2 | Update | 2009/10/30 15:19:30 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
3 | Update | 2010/05/14 18:27:04 | Date analysis concluded |
|
4 | Update | 2011/10/31 16:00:38 | Recruitment status Date analysis concluded Publication of results URL related to results and publications Results Results |